Profile
Esphera SynBio is a pre-clinical company developing the next generation of exosome-based therapeutics. Their proprietary technology enables the generation of bespoke exosomes by modifying producer cells thereby obviating the need to harvest and then modify exosomes. These designer exosomes can be targeted to specific cell types and engineered to contain one or more therapeutic payloads. Engineered exosomes represent a new and exciting opportunity for drug developers as they offer unique advantages over traditional drug delivery. Esphera is developing a pipeline of exosome-based therapeutics and vaccines to solve for challenges across oncology, cell and gene therapy and infectious disease.
![Esphera SynBio Esphera SynBio logo](/sites/default/files/styles/col_4/public/event-logos/Esphera-logo-2024.png?itok=G_PPYdMW)
Website
Contact
-
Brian Lichty, CEOTel: +1 519-771-5577Email: blichty@espherasynbio.ca
-
-
-
-
-
Event details
Date: June 3 - 6, 2024
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
42 in total
-
20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for improved…
-
Altis Labs is a computational imaging company advancing precision medicine. The company believes that medical imaging…
-
CCRM is a Canadian public-private partnership established with seed funding by the Government of…
-
The City of Brampton Economic Development Office provides business connections, site selection services and access to…
-
Mississauga's life sciences sector is a thriving hub of innovation and growth. With a highly skilled workforce and…
-
Clinical Trials Ontario (CTO) is a leading organization in the clinical trials community dedicated to…
-
Covar Pharmaceuticals delivers customized services for pharmaceutical development of new or existing drugs, novel…
-
Custom Biologics provides regulatory compliant potency testing and assay services for all phases of biotherapeutic drug…
-
Esphera SynBio is a pre-clinical company developing the next generation of exosome-based therapeutics. Their…
-
For over two decades, Toronto area-based GL CHEMTEC has been dedicated to delivering innovative solutions…
-
HDAX Therapeutics is pioneering best-in-class therapeutics for neurological and cardiovascular diseases. Leveraging its…
-
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel bioconjugate therapeutics, such…
-
Muse is pioneering brain health through its industry-leading EEG…
-
Hamilton’s Economic Development Office (Invest in Hamilton) is the central point of contact for business assistance,…
-
JN Nova Pharma is developing novel therapeutics to address a particular group of Long COVID patients, who…
-
Kingston Economic Development's aim is to support life sciences companies looking to enter the Canadian market and…
-
Life Sciences Ontario is a not-for-profit organization that represents and promotes Ontario’s vibrant and diverse life…
-
Lumerate is a Toronto-based software company specializing in intelligence about the drug development sector and other…
-
Mediphage has developed a proprietary and scalable E. coli-based manufacturing process for the production of ministring…
-
Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small molecules…
-
Nucro-Technics is a full-service Contract Support Organization that specializes in the conduct of both…
-
Omnium Global’s vision is to accelerate timelines to market for an impact on global health by helping companies beat…
-
OBIO (Ontario BioScience Innovation Organization) is a Canadian life science accelerator supporting…
-
OICR is Ontario’s Cancer Research Institute. It brings together people from across the province and around the…
-
Oxford Cancer Analytics (OXcan) is creating a paradigm shift in early disease detection, monitoring, and…
-
panCELLa and Pluristyx Company, is an advanced therapy tools and services company whose primary mission is to help…
-
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
-
PlantForm develops and manufactures proteins, antibodies, and vaccines at low cost using its green, plant-based,…
-
PolyAnalytik, Inc. is a CRO laboratory that specializes in…
-
ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its platform…
-
PurMinds is a neuro-medicine development and API supply company…
-
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and tissue…
-
Specific Biologics’ mission is to develop therapeutics to treat or cure disease through precision gene editing. Its…
-
SpinUp is the University of Toronto’s wet lab-based, early-stage startup incubator. Located in Mississauga, SpinUp…
-
Stiris is a clinical trial management company conducting Phase I-IIIB trials for biotech and biopharma. Located in…
-
The Synapse Consortium represents Canada’s leading health research and education cluster, including more than 34,000…
-
TheraVac Biologics is developing vaccines and immunotherapies for diseases caused by misfolded protein aggregates and/…
-
Since 2008, TIAP has been building relationships with Toronto’s top research institutions to identify the…
-
Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide for…
-
UHN is Canada’s largest and leading research hospital, consisting of six research institutes located…
-
VeriLuce Therapeutics is an R&D/early-stage drug development company currently developing novel small molecules…
-
Virica is a viral vector enhancer company. It has pioneered a new enhancer category called Viral Sensitizers (VSE…